Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review

Cancer Genetics and Cytogenetics

Volumn 193, Issue 2, 2009, Pages 98-103

  Tošić, Nataša ^a   Stojiljković, Maja ^a   Colović, Nataša ^b   Čolović, Milica ^b   Pavlović, Sonja ^a  

^a INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CYTARABINE; DOXORUBICIN; HEMOGLOBIN; NUCLEOPORIN 98; PROTEIN HOXC13; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; CHROMOSOME 11P; CHROMOSOME 12Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 12; CLINICAL FEATURE; CONTINUOUS INFUSION; CYTOGENETICS; FEMALE; FUSION GENE; GENE MUTATION; HUMAN; LEUKOCYTOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENE DUPLICATION; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MUTATION; NUCLEAR PORE COMPLEX PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 68049142925     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.03.007     Document Type: Article

References (32)

1. Rabbitts T.H. Chromosomal translocations in human cancer. Nature 372 (1994) 143-149
2. Griffis E.R., Altan N., Lippincott-Schwartz J., and Powers M.A. Nup98 is a mobile nucleoporin with transcription-dependent dynamics. Mol Biol Cell 13 (2002) 1282-1297
3. Slape C., and Aplan P.D. The role of NUP98 gene fusions in hematologic malignancy. Leuk Lymphoma 45 (2004) 1341-1350
4. Pan Q., Zhu Y.J., Gu B.W., Cai X., Bai X.T., Yun H.Y., Zhu J., Chen B., Weng L., Chen Z., Xue Y.Q., and Chen S.J. A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29p13;p15)del(3)(q29) translocation. Oncogene 27 (2008) 3414-3423
5. Gehring W.J., Affolter M., and Burglin T. Homeodomain proteins. Annu Rev Biochem 63 (1994) 487-526
6. Argiropoulos B., and Humphries R.K. Hox genes in hematopoiesis and leukemogenesis. Oncogene 26 (2007) 6766-6776
7. Abramovich C., and Humphries R.K. Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 12 (2005) 210-216
8. Kasper L.H., Brindle P.K., Schnabel C.A., Pritchard C.E., Cleary M.L., and van Deursen J.M. CREB binding protein interacts with nucleoprotein-specific FG repeats that activate transcription and mediate NUP98- HOXA9 oncogenicity. Mol Cell Biol 19 (1999) 764-776
9. Borrow J., Shearman A.M., Stanton Jr. V.P., Becher R., Collins T., Williams A.J., Dubé I., Katz F., Kwong Y.L., Morris C., Ohyashiki K., Toyama K., Rowley J., and Housman D.E. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 12 (1996) 159-167
10. Nakamura T., Largaespada D.A., Lee M.P., Johnson L.A., Ohyashiki K., Toyama K., Chen S.J., Willman C.L., Chen I.M., Feinberg A.P., Jenkins N.A., Copeland N.G., and Shaughnessy Jr. J.D. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukemia. Nat Genet 12 (1996) 154-158
11. Suzuki A., Ito Y., Sashida G., Honda S., Katagiri T., Fujino T., Nakamura T., and Ohyashiki K. t(7;11)(p15;p15) Chronic myeloid leukaemia developed into blastic transformation showing a novel NUP98/ HOXA11 fusion. Br J Haematol 116 (2002) 170-172
12. Taketani T., Taki T., Ono R., Kobayashi Y., Ida K., and Hayashi Y. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13 but not HOXA9. Genes Chromosomes Cancer 34 (2002) 437-443
13. Fujino T., Suzuki A., Ito Y., Ohyashiki K., Hatano Y., Miura I., and Nakamura T. Single-translocation and double-chimeric transcripts of NUP98- HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15). Blood 99 (2002) 1428-1433
14. Raza-Egilmez S.Z., Jani-Sait S.N., Grossi M., Higgins M.J., Shows T.B., and Aplan P.D. NUP98- HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res 58 (1998) 4269-4273
15. Taketani T., Taki T., Shibuya N., Ito E., Kitazawa J., Terui K., and Hayashi Y. The HOXD11 gene is fused to the NUP98 gene in acute myeloid leukemia with t(2;11)(q31;p15). Cancer Res 62 (2002) 33-37
16. Taketani T., Taki T., Shibuya N., Kikuchi A., Hanada R., and Hayashi Y. Novel NUP98- HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13). Cancer Res 62 (2002) 4571-4574
17. Panagopoulos I., Isaksson M., Billström R., Strömbeck B., Mitelman F., and Johansson B. Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13). Genes Chromosomes Cancer 36 (2003) 107-112
18. Yanada M., Matsuo K., Suzuki T., Kiyoi H., and Naoe T. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis. Leukemia 19 (2005) 1345-1349
19. Kottaridis P.D., Gale R.E., Frew M.E., Harrison G., Langabeer S.E., Belton A.A., Walker H., Wheatley K., Bowen D.T., Burnett A.K., Goldstone A.H., and Linch D.C. The presence of FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98 (2001) 1752-1759
20. Colović N., Tosić N., Aveić S., Djurić M., Milić N., Bumbasirević V., Colović M., and Pavlović S. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Ann Hematol 86 (2007) 741-747
21. Gu B.W., Wang Q., Wang J.M., Xue Y.Q., Fang J., Wong K.F., Chen B., Shi Z.Z., Shi J.Y., Bai X.T., Wu D.H., Chen Z., and Chen S.J. Major form of NUP98/ HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity. Leukemia 17 (2003) 1858-1864
22. Flagiello D., Gibaud A., Dutrillaux B., Poupon M.F., and Malfoy B. Distinct patterns of all-trans retinoic acid dependent expression of HOXB and HOXC homeogenes in human embryonal and small-cell lung carcinoma cell lines. FEBS Lett 415 (1997) 263-267
23. Kiyoi H., Naoe T., Yokota S., Nakao M., Minami S., Kuriyama K., Takeshita A., Saito K., Hasegawa S., Shimodaira S., Tamura J., Shimazaki C., Matsue K., Kobayashi H., Arima N., Suzuki R., Morishita H., Saito H., Ueda R., and Ohno R. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia 11 (1997) 1447-1452
24. Nishiyama M., Arai Y., Tsunematsu Y., Kobayashi H., Asami K., Yabe M., Kato S., Oda M., Eguchi H., Ohki M., and Kaneko Y. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome. Genes Chromosomes Cancer 26 (1999) 215-220
25. Wong K.F., Kwong Y.L., and So C.C. De novo AML with trilineage myelodysplasia and a novel t(11;12)(p15;q13). Cancer Genet Cytogenet 100 (1998) 49-51
26. Roulston D., Espinosa III R., Nucifora G., Larson R.A., Le Beau M.M., and Rowley J.D. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 92 (1998) 2879-2885
27. La Starza R., Trubia M., Crescenzi B., Matteucci C., Negrini M., Martelli M.F., Pelicci P.G., and Mecucci C. Human homeobox gene HOXC13 is the partner of NUP98 in adult acute myeloid leukemia with t(11;12)(p15;q13). Genes Chromosomes Cancer 36 (2003) 420-423
28. Pineault N., Abramovich C., Ohta H., and Humphries R.K. Differential and common leukemogenic potentials of multiple NUP98-HOX fusion proteins alone or with Meis1. Mol Cell Biol 24 (2004) 1907-1917
29. Kelly L.M., Kutok J.L., Williams I.R., Boulton C.L., Amaral S.M., Curley D.P., Ley T.J., and Gilliland D.G. PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci U S A 99 (2002) 8283-8288
30. Schessl C., Rawat V.P., Cusan M., Deshpande A., Kohl T.M., Rosten P.M., Spiekermann K., Humphries R.K., Schnittger S., Kern W., Hiddemann W., Quintanilla-Martinez L., Bohlander S.K., Feuring-Buske M., and Buske C. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 115 (2005) 2159-2168
31. Palmqvist L., Argiropoulos B., Pineault N., Abramovich C., Sly L.M., Krystal G., Wan A., and Humphries R.K. The Flt3 receptor tyrosine kinase collaborates with NUP98- HOX fusion in acute myeloid leukemia. Blood 108 (2006) 1030-1036
32. Gilliland D.G., and Tallman M.S. Focus on acute leukemias. Cancer Cell 1 (2002) 417-420